CONGRESS COVERAGE: ASCO 2021 – FOCUS ON GI

Expert perspectives and strategic insights on the latest therapeutic developments in GI cancer treatment from the ASCO GI 2021 congress, and implications on individualized clinical decision-making.

January 21, 2021

Faculty Chair

Axel Grothey, MD

West Cancer Center, TN, USA

FACULTY MEMBERS

Dirk Arnold, MD, PhD
University of Hamburg and Asklepios Tumor Center
Hamburg, Germany

Scott Kopetz, MD, PhD
MD Anderson Cancer Center
Houston, TX, USA

Fotios Loupakis, MD, PhD
Veneto Institute of Oncology
Padua, Italy

Tanios S. Bekaii-Saab, MD
Mayo Clinic
Phoenix, AZ, USA

Cathy Eng, MD, FACP
Vanderbilt University Medical Center
Nashville, TN, USA

David Ilson, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY, USA

Eric Van Cutsem, MD, PhD
University of Leuven
Leuven, Belgium

Agenda

Export meeting topics

View Agenda

Sample Report

Start discovering the insights

View Report

KEY TAKEAWAYS AND STRATEGIC INSIGHTS

The report that will be produced on the basis of the meeting will discuss the following topics

  • Colorectal Cancer – Chemotherapy and Targeted Therapy
  • Colorectal Cancer – Immunotherapy
  • Hepatocellular Carcinoma
  • Gastroesophageal Cancers
  • Pancreatic Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.